Your browser doesn't support javascript.
loading
The price and value of therapeutic synergy in liver cancer.
Pinato, David J; D'Alessio, Antonio; Celsa, Ciro; Manfredi, Giulia F; Fulgenzi, Claudia A M.
Afiliación
  • Pinato DJ; Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.
  • D'Alessio A; Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Celsa C; Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Pale
  • Manfredi GF; Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK; Division of Internal Medicine, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Fulgenzi CAM; Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK; Department of Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy.
Lancet ; 402(10408): 1108-1110, 2023 09 30.
Article en En | MEDLINE | ID: mdl-37499669
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Neoplasias Hepáticas Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Neoplasias Hepáticas Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article